Asia-Pacific
ASEAN and the United States agreed to link early detection, genomic surveillance, big-data analytics and One Health. The 2027–2030 work plan will show whether uneven laboratory capacity can become a durable regional warning system.
Americas
CMS is testing direct, outcomes-linked Medicare payments to technology organizations for chronic care as the FDA rethinks how generative medical AI should be evaluated, monitored and integrated safely.
Americas
TPG is exploring a sale of claims-payment platform Lyric at a reported $5 billion valuation, testing how investors price healthcare data, embedded payer workflows and governed AI as automation reshapes payment integrity.
EMEA
Spire Healthcare’s £1.03 billion takeover promises faster investment in hospitals and technology, but its impact will turn on debt, data governance and how the group balances private growth with NHS-funded care.
Americas
A new HIMSS survey finds 73% of patients welcome healthcare AI when a clinician remains involved, sharpening the case for visible oversight, accountable workflows and patient choice as U.S. adoption accelerates.
EMEA
Ireland’s data regulator fined the HSE €645,000 after 12 inspections found systemic failures in paper medical-record storage, turning a physical archive breakdown into a test of health information governance.
Asia-Pacific
Novartis licensed South Korea’s Alteogen drug-delivery platform in a deal worth up to $3.22 billion, extending the race to shift complex biologic treatments from intravenous infusions to faster injections.
Americas
Arkansas is directing $149.3 million to rural telehealth, patient monitoring, emergency data exchange and AI-enabled clinical rooms, testing whether connected infrastructure can translate into durable access and measurable care gains.
EMEA
Patient-reported errors in NHS AI-generated notes are testing whether rapid adoption can deliver administrative gains without compromising record accuracy, consent, accountability and trust across England.
Asia-Pacific
A Mumbai hospital says ambient AI now produces nearly 90% of progress notes and handovers. Its platform-first rollout shows how governance, multilingual performance and human review determine whether documentation AI can safely scale.
Americas
Boston Scientific plans to resume some product shipments after a cyberattack disrupted manufacturing, ordering and remote-monitoring activations, testing the resilience of a major medical-device supply chain.
Americas
August 27, 2026 Dear Fellows, For those I have not yet had the opportunity to meet, I’m Ken Deans, President & CEO of Health Sciences South Carolina, the parent company of Health Data Management. I have had the privilege of working with many of you already, some for as